Diagnosis and treatment of the neutrophilic dermatoses (pyoderma gangrenosum, Sweet's syndrome)

Dermatologic Therapy

Volumn 24, Issue 2, 2011, Pages 273-284

  Dabade, Tushar S ^a   Davis, Mark D P ^a  

^a MAYO CLINIC   (United States)

Author keywords

Hospitalized patient; Neutrophilic dermatoses; Pyoderma gangrenosum; Sweet's syndrome

Indexed keywords

ADALIMUMAB; ALEFACEPT; ALPHA INTERFERON; AZATHIOPRINE; BENZOYL PEROXIDE; CHLORAMBUCIL; CHLORMETHINE; CLOFAZIMINE; COLCHICINE; CROMOGLYCATE DISODIUM; CYCLOSPORIN; DAPSONE; ETANERCEPT; INDOMETACIN; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINE; PIMECROLIMUS; PLATELET DERIVED GROWTH FACTOR; POTASSIUM IODIDE; PREDNISONE; TACROLIMUS;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ARTICLE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; LABORATORY TEST; PHYSICAL EXAMINATION; PYODERMA GANGRENOSUM; SKIN BIOPSY;

DIAGNOSIS, DIFFERENTIAL; HUMANS; PREDICTIVE VALUE OF TESTS; PYODERMA GANGRENOSUM; SKIN; SWEET SYNDROME; TREATMENT OUTCOME;

EID: 79952751292     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2011.01403.x     Document Type: Article

References (81)

1. Weenig RH, Davis MD, Dahl PR, Su WP. Skin ulcers misdiagnosed as pyoderma gangrenosum. N Engl J Med 2002: 347: 1412-1418. (Pubitemid 35239713)
2. Bennett ML, Jackson JM, Jorizzo JL, Fleischer AB Jr, White WL, Callen JP. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine 2000: 79: 37-46.
3. von den Driesch P. Pyoderma gangrenosum: a report of 44 cases with follow-up. Br J Dermatol 1997: 137: 1000-1005.
4. Prystowsky JH, Kahn SN, Lazarus GS. Present status of pyoderma gangrenosum. Review of 21 cases. Arch Dermatol 1989: 125: 57-64.
5. Farhi D. The clinical and histopathological description of geometric phagedenism (pyoderma gangrenosum) by Louis Brocq one century ago. Arch Dermatol 2008: 144: 755.
6. Brunsting LAGW, O'Leary PA. Pyoderma (echthyma) gangrenosum. Clinical and experimental observations in five cases occurring in adults. Arch Derm Syphilol 1930: 22: 655-680.
7. Su WP, Davis MD, Weenig RH, Powell FC, Perry HO. Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol 2004: 43: 790-800. (Pubitemid 39529936)
8. Powell FC, Schroeter AL, Su WP, Perry HO. Pyoderma gangrenosum: a review of 86 patients. Q J Med 1985: 55: 173-186. (Pubitemid 15047362)
9. Perry HO, Winkelmann RK. Bullous pyoderma gangrenosum and leukemia. Arch Dermatol 1972: 106: 901-905.
10. O'Loughlin S, Perry HO. A diffuse pustular eruption associated with ulcerative colitis. Arch Dermatol 1978: 114: 1061-1064.
11. Wilson-Jones E, Winkelmann RK. Superficial granulomatous pyoderma: a localized vegetative form of pyoderma gangrenosum. J Am Acad Dermatol 1988: 18: 511-521. (Pubitemid 18082465)
12. Quimby SR, Gibson LE, Winkelmann RK. Superficial granulomatous pyoderma: clinicopathologic spectrum. Mayo Clin Proc 1989: 64: 37-43. (Pubitemid 19044495)
13. Davis MD, Alexander JL, Prawer SE. Pyoderma gangrenosum of the breasts precipitated by breast surgery. J Am Acad Dermatol 2006: 55: 317-320. (Pubitemid 44038020)
14. Sheldon DG, Sawchuk LL, Kozarek RA, Thirlby RC. Twenty cases of peristomal pyoderma gangrenosum: diagnostic implications and management. Arch Surg 2000: 135: 564-568, discussion 568-569.
15. Su WP, Schroeter AL, Perry HO, Powell FC. Histopathologic and immunopathologic study of pyoderma gangrenosum. J Cutan Pathol 1986: 13: 323-330. (Pubitemid 16009117)
16. Bellini V, Simonetti S, Lisi P. Successful treatment of severe pyoderma gangrenosum with pimecrolimus cream 1%. J Eur Acad Dermatol Venereol 2008: 22: 113-115.
17. Chiba T, Isomura I, Suzuki A, Morita A. Topical tacrolimus therapy for pyoderma gangrenosum. J Dermatol 2005: 32: 199-203.
18. Azizan NZ, Gangaram HB, Hussein SH. A novel therapy for the treatment of pyoderma gangrenosum. Med J Malaysia 2008: 63: 51-54.
19. Lyon CC, Stapleton M, Smith AJ, Mendelsohn S, Beck MH, Griffiths CE. Topical tacrolimus in the management ofperistomal pyoderma gangrenosum. J Dermatolog Treat 2001: 12: 13-17. (Pubitemid 32385592)
20. Langenbach N, Goetz A, Hohenleutner U, Landthaler M. Effectiveness of 4% disodium cromoglycate in the treatment of disseminated pyoderma gangrenosum. Acta Derm Venereol 1996: 76: 501-502. (Pubitemid 26398112)
21. Tsele E, Yu RC, Chu AC. Pyoderma gangrenosum - response to topical nitrogen mustard. Clin Exp Dermatol 1992: 17: 437-440.
22. Vereecken P, Wautrecht JC, De Dobbeleer G, Heenen M. A case of pyoderma gangrenosum stabilized with lymecycline, topical benzoyl peroxide and treated by autograft. Dermatology 1997: 195: 50-51. (Pubitemid 27326711)
23. Braun-Falco M, Stock K, Ring J, Hein R. Topical platelet-derived growth factor accelerates healing of myelodysplastic syndrome-associated pyoderma gangrenosum. Br J Dermatol 2002: 147: 829-831. (Pubitemid 35286190)
24. Patel GK, Rhodes JR, Evans B, Holt PJ. Successful treatment of pyoderma gangrenosum with topical 0.5% nicotine cream. J Dermatolog Treat 2004: 15: 122-125. (Pubitemid 38477952)
25. Goldstein F, Krain R, Thornton JJ. Intralesional steroid therapy of pyoderma gangrenosum. J Clin Gastroenterol 1985: 7: 499-501. (Pubitemid 16175468)
26. Mrowietz U, Christophers E. Clearing of pyoderma gangrenosum by intralesional cyclosporin A. Br J Dermatol 1991: 125: 499.
27. Johnson RB, Lazarus GS. Pulse therapy. Therapeutic efficacy in the treatment of pyoderma gangrenosum. Arch Dermatol 1982: 118: 76-84.
28. Elgart G, Stover P, Larson K, et al. Treatment of pyoderma gangrenosum with cyclosporine: results in seven patients. J Am Acad Dermatol 1991: 24: 83-86.
29. Schmidt C, Wittig BM, Moser C, Zeitz M, Stallmach A. Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's disease. Aliment Pharmacol Ther 2006: 24: 343-350. (Pubitemid 43972902)
30. Brooklyn TN, Dunnill MG, Shetty A, et al. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut 2006: 55: 505-509.
31. Roy DB, Conte ET, Cohen DJ. The treatment of pyoderma gangrenosum using etanercept. J Am Acad Dermatol 2006: 54: S128-S134. (Pubitemid 43243487)
32. Heffernan MP, Anadkat MJ, Smith DI. Adalimumab treatment for pyoderma gangrenosum. Arch Dermatol 2007: 143: 306-308. (Pubitemid 46465720)
33. Foss CE, Clark AR, Inabinet R, Camacho F, Jorizzo JL. An open-label pilot study of alefacept for the treatment of pyoderma gangrenosum. J Eur Acad Dermatol Venereol 2008: 22: 943-949.
34. Eaton PA, Callen JP. Mycophenolate mofetil as therapy for pyoderma gangrenosum. Arch Dermatol 2009: 145: 781-785.
35. Miranda MF. Pyoderma gangrenosum treated with sulfasalazine and dapsone. Indian J Dermatol Venereol Leprol 2002: 68: 160-161.
36. Baumgart DC, Wiedenmann B, Dignass AU. Successful therapy of refractory pyoderma gangrenosum and periorbital phlegmona with tacrolimus (FK506) in ulcerative colitis. Inflamm Bowel Dis 2004: 10: 421-424. (Pubitemid 39029185)
37. Burruss JB, Farmer ER, Callen JP. Chlorambucil is an effective corticosteroid-sparing agent for recalcitrant pyoderma gangrenosum. J Am Acad Dermatol 1996: 35: 720-724. (Pubitemid 26389471)
38. Cummins DL, Anhalt GJ, Monahan T, Meyerle JH. Treatment of pyoderma gangrenosum with intravenous immunoglobulin. Br J Dermatol 2007: 157: 1235-1239. (Pubitemid 350115690)
39. Paolini O, Hebuterne X, Flory P, Charles F, Rampal P. Treatment of pyoderma gangrenosum with colchicine. Lancet 1995: 345: 1057-1058.
40. Smith JB, Shenefelt PD, Soto O, Valeriano J. Pyoderma gangrenosum in a patient with cryoglobulinemia and hepatitis C successfully treated with interferon alfa. J Am Acad Dermatol 1996: 34: 901-903. (Pubitemid 26143878)
41. Wasserteil V, Bruce S, Sessoms SL, Guntupalli KK. Pyoderma gangrenosum treated with hyperbaric oxygen therapy. Int J Dermatol 1992: 31: 594-596.
42. Dean SJ, Nieber S, Hickerson WL. The use of cultured epithelial autograft in a patient with idiopathic pyoderma gangrenosum. Ann Plast Surg 1991: 26: 194-195.
43. Seishima M, Mizutani Y, Shibuya Y, Nagasawa C, Aoki T. Efficacy of granulocyte and monocyte adsorption apheresis for three cases of refractory pyoderma gangrenosum. Ther Apher Dial 2007: 11: 177-182. (Pubitemid 46716159)
44. Kaminska R, Ikaheimo R, Hollmen A. Plasmapheresis and cyclophosphamide as successful treatments for pyoderma gangrenosum. Clin Exp Dermatol 1999: 24: 81-85. (Pubitemid 29223013)
45. Sanders CJ, Hulsmans RF. Successful treatment of pyoderma gangrenosum with topical 5-aminosalicylic acid. Cutis 1993: 51: 262-264.
46. Kumar R. Glucocorticoid-induced osteoporosis. Curr Opin Nephrol Hypertens 2001: 10: 589-595. (Pubitemid 32783807)
47. Mir-Madjlessi SH, Taylor JS, Farmer RG. Clinical course and evolution of erythema nodosum and pyoderma gangrenosum in chronic ulcerative colitis: a study of 42 patients. Am J Gastroenterol 1985: 80: 615-620. (Pubitemid 15040873)
48. Sweet R. An acute febrile neutrophilic dermatosis. Br J Dermatol 1964: 76: 349-356.
49. Fett DL, Gibson LE, Su WP. Sweet's syndrome: systemic signs and symptoms and associated disorders. Mayo Clin Proc 1995: 70: 234-240.
50. Gottlieb CC, Mishra A, Belliveau D, Green P, Heathcote JG. Ocular involvement in acute febrile neutrophilic dermatosis (Sweet syndrome): new cases and review of the literature. Surv Ophthalmol 2008: 53: 219-226. (Pubitemid 351685725)
51. Kemmett D, Hunter JA. Sweet's syndrome: a clinicopathologic review of twenty-nine cases. J Am Acad Dermatol 1990: 23: 503-507. (Pubitemid 20281689)
52. Robbins CM, Mason SE, Hughey LC. Sweet syndrome with pulmonary involvement in a healthy young woman. Arch Dermatol 2009: 145: 344-346.
53. Astudillo L, Sailler L, Launay F, et al. Pulmonary involvement in Sweet's syndrome: a case report and review of the literature. Int J Dermatol 2006: 45: 677-680. (Pubitemid 44056667)
54. Lazarus AA, McMillan M, Miramadi A. Pulmonary involvement in Sweet's syndrome (acute febrile neutrophilic dermatosis). Preleukemic and leukemic phases of acute myelogenous leukemia. Chest 1986: 90: 922-924.
55. Thurnheer R, Stammberger U, Hailemariam S, Russi EW. Bronchial manifestation of acute febrile neutrophilic dermatosis (Sweet's syndrome). Eur Respir J 1998: 11: 978-980. (Pubitemid 28231297)
56. Bouw J, Kater AP, van Tongeren J, Schultz MJ. Upper-airway obstruction instigated by Sweet's syndrome. Med Sci Monit 2007: 13: CS53-CS55.
57. Dorenkamp M, Weikert U, Meyer R, Schwimmbeck PL, Morguet AJ. Heart failure in acute febrile neutrophilic dermatosis. Lancet 2003: 362: 1374. (Pubitemid 37338338)
58. Hayashi I, Hosoda Y, Kawasaki S, Yamamoto T, Dohi S, Kawai S. Aortic and mitral valve replacement in a patient with acute febrile neutrophilic dermatosis (Sweet's syndrome): report of a case. Surg Today 2001: 31: 810-813. (Pubitemid 32955328)
59. Shimizu K. Neutrophilic infiltration of the myocardium in a patient with myelodysplastic syndrome. Am J Hematol 1998: 58: 337-338. (Pubitemid 28346024)
60. Guia JM, Frias J, Castro FJ, Gracian M. Cardiovascular involvement in a boy with Sweet's syndrome. Pediatr Cardiol 1999: 20: 295-297. (Pubitemid 29279636)
61. Muster AJ, Bharati S, Herman JJ, Esterly NB, Gonzales-Crussi F, Holbrook KA. Fatal cardiovascular disease and cutis laxa following acute febrile neutrophilic dermatosis. J Pediatr 1983: 102: 243-248. (Pubitemid 13194707)
62. Druschky A, von den Driesch P, Anders M, Claus D, Neundorfer B. Sweet's syndrome (acute febrile neutrophilic dermatosis) affecting the central nervous system. J Neurol 1996: 243: 556-557. (Pubitemid 26239713)
63. Hisanaga K, Iwasaki Y, Itoyama Y. Neuro-sweet disease: clinical manifestations and criteria for diagnosis. Neurology 2005: 64: 1756-1761. (Pubitemid 40695812)
64. Cohen PR, Holder WR, Tucker SB, Kono S, Kurzrock R. Sweet syndrome in patients with solid tumors. Cancer 1993: 72: 2723-2731. (Pubitemid 23320239)
65. Paydas S, Sahin B, Seyrek E, et al. Sweet's syndrome associated with G-CSF. Br J Haematol 1993: 85: 191-192. (Pubitemid 23291496)
66. von den Driesch P. Sweet's syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol 1994: 31: 535-556, quiz 557-560.
67. Karadogan SK, Baskan EB, Alkan G, Saricaoglu H, Tunali S. Generalized Sweet syndrome lesions associated with Behcet disease: a true association or simply co-morbidity? Am J Clin Dermatol 2009: 10: 331-335.
68. Gillott TJ, Whallett AJ, Struthers GR, Ilchyshyn A. Concurrent Sweet's syndrome (acute febrile neutrophilic dermatosis), erythema nodosum and sarcoidosis. Clin Exp Dermatol 1997: 22: 54-56. (Pubitemid 27368411)
69. Cohen PR, Kurzrock R. Sweet's syndrome revisited: a review of disease concepts. Int J Dermatol 2003: 42: 761-778. (Pubitemid 37304040)
70. Su WP, Liu HN. Diagnostic criteria for Sweet's syndrome. Cutis 1986: 37: 167-174. (Pubitemid 16083666)
71. Weenig RH, Bruce AJ, McEvoy MT, Gibson LE, Davis MD. Neutrophilic dermatosis of the hands: four new cases and review of the literature. Int J Dermatol 2004: 43: 95-102. (Pubitemid 38256439)
72. Case JD, Smith SZ, Callen JP. The use of pulse methylprednisolone and chlorambucil in the treatment of Sweet's syndrome. Cutis 1989: 44: 125-129. (Pubitemid 19221682)
73. Horio T, Imamura S, Danno K, Furukawa F, Ofuji S. Treatment of acute febrile neutrophilic dermatosis (Sweet's syndrome) with potassium iodide. Dermatologica 1980: 160: 341-347. (Pubitemid 10128846)
74. Sitjas D, Puig L, Cuatrecasas M, De Moragas JM. Acute febrile neutrophilic dermatosis (Sweet's syndrome). Int J Dermatol 1993: 32: 261-268. (Pubitemid 23124202)
75. Maillard H, Leclech C, Peria P, Avenel-Audran M, Verret JL. Colchicine for Sweet's syndrome. A study of 20 cases. Br J Dermatol 1999: 140: 565-566. (Pubitemid 29182913)
76. Jeanfils S, Joly P, Young P, Le Corvaisier-Pieto C, Thomine E, Lauret P. Indomethacin treatment of eighteen patients with Sweet's syndrome. J Am Acad Dermatol 1997: 36: 436-439. (Pubitemid 27131968)
77. Bianchi L, Masi M, Hagman JH, Piemonte P, Orlandi A. Systemic interferon-alpha treatment for idiopathic Sweet's syndrome. Clin Exp Dermatol 1999: 24: 443-445. (Pubitemid 30010183)
78. Yamauchi PS, Turner L, Lowe NJ, Gindi V, Jackson JM. Treatment of recurrent Sweet's syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanercept. J Am Acad Dermatol 2006: 54: S122-S126. (Pubitemid 43243485)
79. Browning CE, Dixon JE, Malone JC, Callen JP. Thalidomide in the treatment of recalcitrant Sweet's syndrome associated with myelodysplasia. J Am Acad Dermatol 2005: 53: S135-S138. (Pubitemid 40961828)
80. Brodkin RH, Schwartz RA. Sweet's syndrome with myelofi- brosis and leukemia: partial response to interferon. Dermatology 1995: 190: 160-163.
81. Chan HL, Lee YS, Kuo TT. Sweet's syndrome: clinicopathologic study of eleven cases. Int JDermatol 1994: 33: 425-432.